Advanced Search

 

Study ID Status Title Patient Level Data
GL/MIG/001A/92 Completed A double-blind, general practice study to compare GR43175 with paracetamol and metoclopramide in the acute treatment of migraine.
GL/MIG/002 Completed A double-blind general practice study to compare sumatriptan with MigraleveTM in the acute treatment of migraine.MigraleveTM is a trademark of Pfizer
GL/MIG/002A Completed A double-blind general practice study to compare sumatriptan with Migraleve in the acute treatment of migraine.
GL/PNV/001 Completed A randomised, double-blind, placebo-controlled multicentre study to evaluate the efficacy and safety profile of a single 4mg intravenous bolus dose of ondansetron in the prevention of post-operative nausea and emesis in patients having general anaesthesia and undergoing major gynaecological surgery.
GLP106073 Completed A single-blinded randomized, placebo-controlled, staggered-parallel, escalating-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in Subjects with type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
GLP107030 Completed A Single-Blind, Randomized, Placebo-Controlled Study in Healthy Men and Women to Determine the Effect of Single Subcutaneous Injections of GSK716155 on Gastric Emptying Time for Solid and Liquid Components of a Meal Study Listed on ClinicalStudyDataRequest.com
GLP107724 Completed An Open-Label, Randomized, Multi-Site Study to Assess the Pharmacokinetics of Single Subcutaneous Injections of 16mg and 64mg of GSK716155 Administered at Three Different Injection Sites in Adult Male and Female Subjects with Type 2 Diabetes and of Single Subcutaneous Injections of 16mg and 64mg of GSK716155 Administered in the Abdomen of Healthy, Normal Volunteers Study Listed on ClinicalStudyDataRequest.com
GLP107865 Completed Clinical assessment of GSK716155 for Type 2 Diabetes Mellitus -A Phase I/II study to investigate the safety, pharmacokinetics and pharmacodynamics of GSK716155 in Japanese subjects with type 2 diabetes mellitus Study Listed on ClinicalStudyDataRequest.com
GLP110125 Completed A 16-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Doses and Multiple Treatment Regimens of GSK716155, with Byetta as an Open Label Active Reference, in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
GM2006/00037/00 Completed A Phase II Multicentre, Randomised, Double-Blind, Placebo and Active-Controlled, Dose-Ranging, Parallel Group Study of the Safety and Efficacy of a New Chemical Entity When Administered at daily doses of 50 mg, 100 mg, and 150 mg Oral Tablets in Combination with Ondansetron Hydrochloride and Dex ...
GPK:89:06 Completed To Investigate the Pharmacokinetics of Hydroxynaphthoic Acid in Healthy Volunteers
GPK:89:08 Completed Comparison of the Single-Dose Pharmacokinetics of Hydroxynaphthoic Acid in Subjects with Renal Failure and in Healthy Subjects.
GT1109727 Completed Single-Blind, randomised, placebo-controlled first time in human study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single oral escalating doses of GSK1018921 in healty volunteers and a randomized, double-blind, double dummy, placebo controlled, three-way crossover study in a separate cohort of healthy volunteers to test the effect of single doses of GSK1018921 and nicotine on qEEG and MMN in healthy volunteers
GTH001/92 Completed Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomised controlled trial. –Extensive searching has revealed that no clinical study report is available for this study.
GTH001/94 Completed An evaluator-blind, randomised, within-patient comparison of ondansetron given three times daily vs. twice daily with or without dexamathasone vs. metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting in children.
H34/064/V/87 (UK64) Completed The Pharmacokinetics and Bioequivalence of, and Effect of Food on, Lamotrigine Capsules and Tablets
H34/100/V/88 Completed The bioequivalence of lamotrigine tablets and syrup
H34/107-STW881 Completed The pharmacokinetics of lamotrigine in chronic renal failure: Influence of haemodialysis
H34/V/AFC/84/01 Completed Pharmacokinetics of Lamotrigine After Oral and Intravenous Infusion Administration in Normal Volunteers
H34-035-C86 Completed A Multicentre Randomised Double-Blind Placebo Controlled Crossover Trial of Lamotrigine (LTG) as Add-On Therapy in Treatment-Resistant Epilepsy: Australia
H34-049-C87/H34-089-C88 Completed A Multicentre, Double Blind Comparison of the Efficacy and Safety of Lamotrigine and Carbamazepine Monotherapy in Patients with Newly Diagnosed Epilepsy
H34-074-C87 Completed A multicenter, double-blind comparison of the efficacy and safety of lamotrigine and phenytoin monotherapy in patients with newly diagnosed epilepsy.
H3A106104 Terminated An Open Label, Dose Escalation Study With A Double Blind Randomised Placebo Controlled Withdrawal To Examine The Effects Of The Histamine H3 Antagonist GSK189254 In Patients With Narcolepsy.
H3A106308 Completed A double-blind, double-dummy, placebo-controlled, incomplete block, two period crossover study of the histamine H3 antagonist GSK189254 and duloxetine in the electrical hyperalgesia model of central sensitisation in healthy volunteers
H3B109689 Completed A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer’s disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selective histamine H3 receptor antagonist Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.